نتائج البحث - "Miguel, Brito Sanfiel"

1

دورية أكاديمية

Effectiveness and Tolerability of the Intensification of Canagliflozin Dose from 100 mg to 300 mg Daily in Patients with Type 2 Diabetes in Real Life: The INTENSIFY Study

المؤلفون: Juan J. Gorgojo-Martinez, Pablo José Ferreira-Ocampo, Alba Galdón Sanz-Pastor, Jersy Cárdenas-Salas, Teresa Antón-Bravo, Miguel Brito-Sanfiel, Francisca Almodóvar-Ruiz

المصدر: Journal of Clinical Medicine; Volume 12; Issue 13; Pages: 4248

مصطلحات موضوعية: SGLT-2 inhibitor, canagliflozin, type 2 diabetes, switch, intensification

وصف الملف: application/pdf

العلاقة: Cardiovascular Medicine; https://dx.doi.org/10.3390/jcm12134248Test

الإتاحة: https://doi.org/10.3390/jcm12134248Test

View record in BASE

2

دورية أكاديمية

Connected Insulin Pens and Caps: An Expert’s Recommendation from the Area of Diabetes of the Spanish Endocrinology and Nutrition Society (SEEN)

المؤلفون: Tejera-Pérez, Cristina, Chico, Ana, Azriel-Mira, Sharona, Lardiés-Sánchez, Beatriz, Gomez-Peralta, Fernando, Jesús, Amor Fernández Antonio, Amparo, Bartual Rodrigo, Virginia, Bellido, Diego, Bellido Guerrero, Antonio, Botana López Manuel, Miguel, Brito Sanfiel, Gloria, Canovas Molina, Daniel, Cepero Garcia, Ana, Chico Ballesteros, Ignacio, Conget Donlo, Antonio, de Luis Román Daniel, María, Durán Martínez, Alejandra, Duran Rodriguez-Hervada, Javier, Escalada San Martin Francisco, Carlos, Fernández García José, Diego, Fernández García, Elena, García Fernández, Custodia, García Jiménez, Manuel, Gargallo Fernández, Fernando, Gómez Peralta, Cintia, González Blanco, Miguel, González Clemente José, De Villar Noemí, González Pérez, Noelia, Gros Herguido, Miguel, Hernandez Martinez Antonio, Sandra, Herranz Antolin, Esteban, Jódar Gimeno Jose, Beatriz, Lardiés Sánchez, Edurne, Lecumberri Pascual, De La Torre Casares Martin, López, Judith, López Fernández, Gema, López Gallardo, Amparo, Marco Martinez, Rosa, Márquez Pardo, Francisco, Merino Torres Juan, Pedro, Mezquita Raya, Sharona, Mira, Cristóbal, Morales Portillo, Óscar, Moreno Pérez, Manuel, Muñoz Torres, De, Pablos Velasco Pedro Luis, José, Pinés Corrales Pedro, Pilar, Quílez Toboso Rosa, Rebeca, Reyes García, Pedro, Rozas Moreno

المصدر: Diabetes Therapy ; volume 14, issue 7, page 1077-1091 ; ISSN 1869-6953 1869-6961

مصطلحات موضوعية: Endocrinology, Diabetes and Metabolism, Internal Medicine

الإتاحة: https://doi.org/10.1007/s13300-023-01417-1Test

View record in BASE

3

دورية أكاديمية

Predictive Factors of Renal Function Decline in Patients with Type 2 Diabetes Treated with Canagliflozin in the Real-Wecan Study

المؤلفون: Juan J. Gorgojo-Martinez, Miguel Brito-Sanfiel, Teresa Antón-Bravo, Alba Galdón Sanz-Pastor, Jaime Wong-Cruz, Manuel A. Gargallo Fernández

المصدر: Journal of Clinical Medicine; Volume 11; Issue 19; Pages: 5622

مصطلحات موضوعية: SGLT-2 inhibitor, canagliflozin, type 2 diabetes, renal function

وصف الملف: application/pdf

العلاقة: Endocrinology & Metabolism; https://dx.doi.org/10.3390/jcm11195622Test

الإتاحة: https://doi.org/10.3390/jcm11195622Test

View record in BASE

4

دورية أكاديمية

Real-World Clinical Outcomes Associated with Canagliflozin in Patients Aged 65 Years and Older with Type 2 Diabetes Mellitus in Spain: The Old Real-Wecan Study

المؤلفون: Manuel A. Gargallo-Fernández, Alba Galdón Sanz-Pastor, Teresa Antón-Bravo, Miguel Brito-Sanfiel, Jaime Wong-Cruz, Juan J. Gorgojo-Martínez

المصدر: Diabetology; Volume 2; Issue 3; Pages: 165-175

مصطلحات موضوعية: canagliflozin, SGLT-2 inhibitor, elderly patients, type 2 diabetes mellitus, real-world study

وصف الملف: application/pdf

العلاقة: https://dx.doi.org/10.3390/diabetology2030015Test

الإتاحة: https://doi.org/10.3390/diabetology2030015Test

View record in BASE

5

Effectiveness and Tolerability of the Intensification of Canagliflozin Dose from 100 mg to 300 mg Daily in Patients with Type 2 Diabetes in Real Life: The INTENSIFY Study

المؤلفون: Almodóvar-Ruiz, Juan J. Gorgojo-Martinez, Pablo José Ferreira-Ocampo, Alba Galdón Sanz-Pastor, Jersy Cárdenas-Salas, Teresa Antón-Bravo, Miguel Brito-Sanfiel, Francisca

المصدر: Journal of Clinical Medicine; Volume 12; Issue 13; Pages: 4248

مصطلحات موضوعية: SGLT-2 inhibitor, canagliflozin, type 2 diabetes, switch, intensification

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=multidiscipl::69e99736702979c28e46348fbd35100eTest

6

دورية أكاديمية

Real-World Clinical Outcomes Associated with Canagliflozin in Patients with Type 2 Diabetes Mellitus in Spain: The Real-Wecan Study

المؤلفون: Juan J. Gorgojo-Martínez, Manuel A. Gargallo-Fernández, Alba Galdón Sanz-Pastor, Teresa Antón-Bravo, Miguel Brito-Sanfiel, Jaime Wong-Cruz

المصدر: Journal of Clinical Medicine; Volume 9; Issue 7; Pages: 2275

مصطلحات موضوعية: SGLT-2 inhibitor, canagliflozin, type 2 diabetes, switch

وصف الملف: application/pdf

العلاقة: Endocrinology & Metabolism; https://dx.doi.org/10.3390/jcm9072275Test

الإتاحة: https://doi.org/10.3390/jcm9072275Test

View record in BASE

7

Real-World Clinical Outcomes Associated with Canagliflozin in Patients Aged 65 Years and Older with Type 2 Diabetes Mellitus in Spain: The Old Real-Wecan Study

المؤلفون: Jaime E.M. Wong-Cruz, Miguel Brito-Sanfiel, Manuel Gargallo-Fernández, Teresa Antón-Bravo, Alba Galdón Sanz-Pastor, Juan J. Gorgojo-Martinez

المصدر: Diabetology
Volume 2
Issue 3
Pages 15-175

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d35eaecd07a5ee24d1cb70947623cf8Test
https://doi.org/10.3390/diabetology2030015Test

8

دورية أكاديمية

The effect of concomitant DPPIVi use on glycaemic control and hypoglycaemia with insulin glargine 300 U/mL (Gla-300) versus insulin glargine 100 U/mL (Gla-100) in people with type 2 diabetes: A patient-level meta-analysis of EDITION 2 and 3.

المؤلفون: Jean-François Yale, Jeremy Hodson Pettus, Miguel Brito-Sanfiel, Fernando Lavalle-Gonzalez, Ana Merino-Trigo, Peter Stella, Soazig Chevalier, Raffaella Buzzetti

المصدر: PLoS ONE, Vol 13, Iss 1, p e0190579 (2018)

مصطلحات موضوعية: Medicine, Science

وصف الملف: electronic resource

العلاقة: http://europepmc.org/articles/PMC5784896?pdf=renderTest; https://doaj.org/toc/1932-6203Test

الوصول الحر: https://doaj.org/article/8a5e9a7e1ac64e8eb639da9f0c475957Test

View record in DOAJ

النص الكامل

9

Real-World Clinical Outcomes Associated with Canagliflozin in Patients with Type 2 Diabetes Mellitus in Spain: The Real-Wecan Study

المؤلفون: Jaime E.M. Wong-Cruz, Miguel Brito-Sanfiel, Manuel Gargallo-Fernández, Alba Galdón Sanz-Pastor, Teresa Antón-Bravo, Juan J. Gorgojo-Martinez

المصدر: Journal of Clinical Medicine
Volume 9
Issue 7
Journal of Clinical Medicine, Vol 9, Iss 2275, p 2275 (2020)

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d33705a2fe17cf8fa45f984b16ced3c4Test

10

1127-P: Real-World Clinical Outcomes Associated with Canagliflozin 100mg and with Intensification of SGLT2 Inhibitor Therapy Switching to Canagliflozin 300mg in Patients with Type 2 Diabetes Mellitus: The Real-WECAN Study

المؤلفون: Teresa Antón-Bravo, Juan J. Gorgojo-Martinez, Miguel Brito-Sanfiel, Jaime E.M. Wong-Cruz, Manuel Gargallo-Fernández, Alba Galdon

المصدر: Diabetes. 69

مصطلحات موضوعية: Canagliflozin, medicine.medical_specialty, business.industry, Endocrinology, Diabetes and Metabolism, Type 2 Diabetes Mellitus, Retrospective cohort study, medicine.disease, chemistry.chemical_compound, chemistry, Internal medicine, Diabetes mellitus, Cohort, Internal Medicine, Empagliflozin, medicine, Dapagliflozin, business, Adverse effect, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::84645583b35bf0ec3626c1501b01c2a5Test
https://doi.org/10.2337/db20-1127-pTest

تنقيح النتائج